Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 Dec;46(12):881–885. doi: 10.1136/thx.46.12.881

Cystic fibrosis: current survival and population estimates to the year 2000.

J S Elborn 1, D J Shale 1, J R Britton 1
PMCID: PMC463492  PMID: 1792634

Abstract

BACKGROUND: Survival from cystic fibrosis is increasing rapidly. Estimates of the extent of this improvement should allow health care facilities to be planned to deal with the expanding population of patients with cystic fibrosis. Estimates of life expectancy are also essential if accurate information on current prognosis is to be given to parents of an affected child, or to prospective parents deciding whether to proceed with a pregnancy where the fetus may be affected. METHODS: Survival trends in the national data on cystic fibrosis have been analysed to produce estimates of the likely size of the cystic fibrosis population over the next decade and to predict the life expectancy of children born with cystic fibrosis in the years up to 1990. RESULTS: In England and Wales the estimated number of patients with cystic fibrosis is at present about 5200, of whom 3300 (63%) are aged under 16 years. By the year 2000 the total population will increase to 6000, with 3400 (57%) aged under 16. Thus the number of children with cystic fibrosis will remain fairly constant over the next 10 years, whereas adult numbers will increase by about 36% (from 1901 to 2577). The median life expectancy of children with cystic fibrosis born in 1990 is estimated to be 40 years, double that of 20 years ago. CONCLUSION: This study suggests that health service provision for children will not need to change substantially over the next 10 years whereas services for adults will need to increase by about a third. Parents can be counselled that the median life expectancy of a newborn child with cystic fibrosis is currently likely to be of the order of 40 years.

Full text

PDF
881

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colten H. R. Screening for cystic fibrosis; public policy and personal choices. N Engl J Med. 1990 Feb 1;322(5):328–329. doi: 10.1056/NEJM199002013220510. [DOI] [PubMed] [Google Scholar]
  2. Corey M., McLaughlin F. J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi: 10.1016/0895-4356(88)90063-7. [DOI] [PubMed] [Google Scholar]
  3. Cystic fibrosis in the United Kingdom 1977-85: an improving picture. British Paediatric Association Working Party on Cystic Fibrosis. BMJ. 1988 Dec 17;297(6663):1599–1602. doi: 10.1136/bmj.297.6663.1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Huang N. N., Macri C. N., Girone J., Sproul A. Survival of patients with cystic fibrosis. Am J Dis Child. 1970 Oct;120(4):289–295. doi: 10.1001/archpedi.1970.02100090063002. [DOI] [PubMed] [Google Scholar]
  5. Knight R. A., Hodson M. E. Identification of the cystic fibrosis gene. BMJ. 1990 Feb 10;300(6721):345–346. doi: 10.1136/bmj.300.6721.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kollberg H. Incidence and survival curves of cystic fibrosis in Sweden. Acta Paediatr Scand. 1982 Mar;71(2):197–202. doi: 10.1111/j.1651-2227.1982.tb09399.x. [DOI] [PubMed] [Google Scholar]
  7. Lemna W. K., Feldman G. L., Kerem B., Fernbach S. D., Zevkovich E. P., O'Brien W. E., Riordan J. R., Collins F. S., Tsui L. C., Beaudet A. L. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med. 1990 Feb 1;322(5):291–296. doi: 10.1056/NEJM199002013220503. [DOI] [PubMed] [Google Scholar]
  8. Phelan P. D., Allan J. L., Landau L. I., Barnes G. L. Improved survival of patients with cystic fibrosis. Med J Aust. 1979 Apr 7;1(7):261–263. doi: 10.5694/j.1326-5377.1979.tb112071.x. [DOI] [PubMed] [Google Scholar]
  9. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  10. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  11. Ten Kate L. P., Tijmstra T. Carrier screening for cystic fibrosis. Lancet. 1989 Oct 21;2(8669):973–974. doi: 10.1016/s0140-6736(89)90975-6. [DOI] [PubMed] [Google Scholar]
  12. Warwick W. J., Pogue R. E., Gerber H. U., Nesbitt C. J. Survival patterns in cyctic fibrosis. J Chronic Dis. 1975 Dec;28(11-12):609–622. doi: 10.1016/0021-9681(75)90074-0. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES